Caroline Litchfield
Director of Finance/CFO presso IMMUNE DESIGN CORP
Patrimonio netto: 7 M $ in data 31/03/2024
Posizioni attive di Caroline Litchfield
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNE DESIGN CORP | Director/Board Member | 02/04/2019 | - |
| Director of Finance/CFO | - | - | |
| Treasurer | 02/04/2019 | - | |
| MERCK & CO., INC. | Director of Finance/CFO | 01/04/2021 | - |
| Treasurer | 01/01/2018 | 01/04/2021 |
Storia della carriera di Caroline Litchfield
Precedenti posizioni note di Caroline Litchfield
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ORGANON & CO. | Director/Board Member | - | 31/05/2021 |
| FULFORD (INDIA) LIMITED | Director/Board Member | 04/08/2013 | 30/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | - | 23/06/2009 |
Formazione di Caroline Litchfield
| University of Leicester | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 3 |
| India | 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Director/Board Member | 3 |
| Treasurer | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Aziende private | 3 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Borsa valori
- Insiders
- Caroline Litchfield
- Esperienza
